RE
Recordati
REC.MI·BITMilan ITFounded 19264,500 employees
Mid CappharmaPublicRare Disease
Platform: Isturisa Onc
Market Cap
$8B
All Drugs
4
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (REC.MI)
Loading REC.MI stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| REC-7914 | REC-7914 | NDA/BLA | 1 | PLK4 | Bladder CaAlzheimer's | ||
| REC-373 | REC-373 | Phase 1 | 2 | SGLT2 | AMLLGS | ||
| Sotozanubrutinib | REC-9190 | Phase 2/3 | 1 | IL-23 | Fabry | ||
| REC-3246 | REC-3246 | Phase 2/3 | 2 | MDM2 | Breast Ca |
SEC Filings & Financial Documents
SEC filings are not available for BIT-listed companies.
Recordati trades on BIT (IT). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (6)